NKore, a pioneering force in the realm of immunotherapy and diagnostics, has successfully raised $30 million in its latest funding round, propelling the company toward new heights in the fight against cancer and other immune-related diseases. With a specialized focus on Supercharged Natural Killer (NK) Cells, NKore has developed groundbreaking approaches that harness the power of the immune system to target and eliminate malignant cells effectively. This substantial influx of capital will be instrumental in advancing NKore's innovative research programs, expanding clinical trials, and enhancing their cutting-edge technologies aimed at revolutionizing cancer treatment. The funding will also facilitate partnerships with leading research institutions and healthcare providers to investigate the therapeutic potential of Supercharged NK Cells across various cancer types. As NKore continues to push the boundaries of traditional oncology, this strategic investment underscores the confidence investors have in the company's vision and its commitment to improving patient outcomes. The leadership team at NKore is dedicated to translating scientific discoveries into real-world solutions, ensuring that patients have access to the most advanced and effective treatments available. With this funding, NKore is well-positioned to make significant strides in cancer therapeutic development, paving the way for new hope for patients and their families battling against this formidable disease. As NKore embarks on this exciting chapter, the company remains steadfast in its mission to create a brighter, healthier future through innovation in immunotherapy and precision medicine.
Breaking News: NKore Secures $30 Million in Series A Funding for Revolutionary Cancer Treatment Innovations
Recently funded · $30.0M Series aHealthcare
Get the full NKore company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
